Dimension Capital’s $800M third fund shows the intersection of science and compute is booming

The four-year-old firm’s latest fund is 60% larger than its second vehicle announced 18 months ago.

Sightera Biosciences closes €3M pre-seed to expand its patient-derived AI drug discovery platform

Sightera Biosciences, a Belgiantechbio company using generative AI to develop novel small-molecule therapies,has raised €3 million in a pre-seed funding round led by Entourage, Anacura andQBIC.A spin-…

Aardaia bags €5M to build the next generation of crops

Aardaia, a Wageningen-based agritechstartup developing new crop varieties from wild plants, has raised €5 millionin a seed funding round led by Point Nine. Existing investor FoodLabsparticipated in th…

Roundtables: Longevity’s Next Frontier: “Reprogramming” Your Body

Listen to the session or watch below Billions of dollars are flooding into efforts to reverse aging as scientists explore ways to return cells to a younger state. But how far off are these experimental treatments? Will they really work? Watch a conversation exploring longevity’s new focus. Speakers: Mary Beth Griggs, science editor and Jessica…

Graph Therapeutics brings total funding to over $10M to advance precision immunology

Graph Therapeutics, a next-generation techbio company developing precision medicinesfor inflammatory and immune-mediated diseases, has secured a new $5 millioninvestment led by Daphni, the Paris-based…

Inside Interoception: The hidden sense of how you feel inside

MIT Technology Review Explains: Let our writers untangle the complex, messy world of science and technology to help you understand what’s coming next. You can read more from the series here. Your brain lives in the dark space of your skull. Yet it knows when the wind lifts the hairs on your skin, when your heart is…

Apoha emerges from stealth with $36M to build “Liquid State Intelligence” for molecular behaviour

Apoha, a deeptech company pioneering what it calls Liquid State Intelligence emerges from stealth today with $36 million in funding. The round is led by Singular, with participation from Tim Draper’s…

Deep Science Ventures and Medicines Discovery Catapult partner to tackle brain drug delivery

Deep Science Ventures (DSV), a UK-based deeptech venture creator, and Medicines Discovery Catapult (MDC), a life sciences service dedicated to turning drug discovery into commercial breakthroughs, tod…

hephaistos.bio secures €161K to advance sustainable chemical manufacturing

Swiss biotech startup hephaistos.bio hassecured €161,000 (CHF 150,000) from Venture Kick to accelerate the developmentof custom enzyme solutions for pharmaceutical and chemical manufacturing.Chemical …

What happens in Vega$: steroids, swimmers, and a billion-dollar hustle

The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance enhancing drugs — may herald a new business model that the tech industry is ready to embrace.